Eat Smart to Lessen Risk of Prostate Cancer

Recommend to others!

Studies by researchers prove that the individuals need to eat smartly if they want to condense the risk of prostate cancer. Researchers have discovered dietary supplements and foods which will help in condensing this risk. A professor from the University of Kansas is focusing on nutrition with an intention to tackle prostate cancer. An assistant professor by profession, Brian Lindshield, is helping individuals in making them more informed about their diet decision. He encourages individuals to study dietary supplements and foods which can help in reducing the risk of prostate cancer.

Lindshield says that, he is very interested in researching new ways to put off prostate cancer rather than finding out methods of treatment after an individual has been diagnosed with cancer. He has two fold goals in research: He is currently performing basic studies which will scrutinize specific drugs and dietary supplements. National Institute of Health Center along with Johnson Cancer Research Center supports Lindshield and his research by offering grants. His project emphasizes on two drugs:

  • Dutasteride and
  • Finasteride

These two drugs are used while treating benign prostatic hyperplasia, which is an augmentation of the prostrate. Both the drugs hold back the enzymes thereby converting the male hormone testosterone to a further potent form. Finasteride slows down one of these enzymes while dutasteride slows down both of these enzymes. Since these drugs slow down DHT production, they can also prevent the development of prostate cancer. Many clinical tests have proved that both the drugs condense prostate cancer occurrence but at a cost.

The other project is about studying the various dietary supplements which affect the growth of prostate cancer. He is focusing on an extract which is like a shrub and is just like a palm tree. Many men take this extract since it is considered to benefit the prostatic health. He says that he wants to seek how this extract and drugs affect the growth of prostate cancer cells as well as slow down the enzymes which produce DHT. He believes that an insight into the project will help the individuals reduce the risk of prostate cancer.

According to Cancer.org, “other than skin cancer, prostate cancer is the most common cancer in American men. The latest American Cancer Society estimates for prostate cancer in the United States are for 2011:

  • About 240,890 new cases of prostate cancer will be diagnosed
  • About 33,720 men will die of prostate cancer

“About 1 man in 6 will be diagnosed with prostate cancer during his lifetime. More than 2 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today,” they added.

 

Comments

comments

Speak Your Mind

*

Current day month ye@r *